Board of Directors
Dr Geoffrey N Vernon BPharm, PhD, MBA, Ch.Dir.
Non-Executive Chairman
Dr Vernon is a former Executive Director of Rothschild Asset Management and partner of the venture capital group Advent Limited. He joined AMS as a non-executive director in July 1998 and became Chairman in January 2001. He has over 20 years experience in healthcare and life sciences. He is a non-executive chairman and director of a number of quoted and privately owned companies. He is a Chartered Director of the Institute of Directors.
Dr Don W Evans BChemEng, MASc, PhD
Chief Executive Officer
After completing a degree in Chemical Engineering at the University of Queensland and a PhD in Biomedical Engineering at the University of Toronto, Dr Evans joined Johnson & Johnson UK where he worked for 19 years in Research & Development and Manufacturing. He was subsequently appointed as Vice-President of European Operations for Johnson & Johnson Professional. Dr Evans joined AMS in 1997 as Operations Director and was appointed Managing Director of Advanced Woundcare in January 1999.He became Group Chief Executive in January 2000.
Mary G Tavener ACMA, MCT, BA (Hons) Chem (Oxon)
Finance Director
Ms Tavener joined AMS as Finance Director in 1999. Prior to this she was the Group Financial Controller at BTP plc during a period of considerable corporate activity and was involved in the acquisition and disposal of several businesses that repositioned BTP plc as a fine chemical company. Her experience has been gained in manufacturing and she has held financial positions with Cadburys Ltd and Parker Hannifin, a US Engineering Corporation. Prior to BTP plc, she was the Finance Director of Churchill Tableware Ltd.
A. Chris Meredith BSc (Hons)
Commercial Director Group
Mr Meredith joined AMS as Group Commercial Director in July 2005. He began his career in sales for Beecham Pharmaceuticals and has continued to hold commercial roles within the healthcare industry ever since. His experience covers contract manufacturing, product development, clinical research and branded product sales all within the medical device, pharmaceutical or consumer healthcare markets. Mr Meredith has previously held senior commercial positions at Cardinal Health, Banner Pharmacaps, Aster Cephac and Smiths Industries.
R Stephen Harris BPharm, FRPharmS
Non-Executive Director
Mr Harris was appointed as a non-executive director of AMS in January 2001. His career has been in both prescription and consumer healthcare sectors, with sales, marketing and general management experience with MSD, Lilly, Boots and Reckitt & Colman before becoming a main Board Director of Medeva plc. He resigned as a director of Medeva in 1995 to set up his own consultancy business. He now holds non-executive appointments with a number of quoted and privately owned healthcare companies.
Stephen G. Bellamy BCom & ACA (NZ)
Non-Executive Director (appointed 20 February 2007)
Mr Bellamy was appointed as non-executive director of AMS on 20 February 2007. He is currently Chairman of the First Close Technology Fund which invests in early stage UK technology companies. Formerly an executive director of Sherwood International plc and Brierley investments’ London operations he has held a number of non-executive directorships including Budgens plc, the food retailer acquired in 2002 by the Musgrave Group for £315 million and Dr. Foster Limited, a provider of information to the UK health industry. He is a former member of the advisory committeee to ISIS Capital plc and is a qualified chartered accountant.
Published : 10/04/2009 16:16:52